Specialist Sector: Healthcare

What sets us apart

We take a sector-focused approach, providing deep expertise across pharma and life sciences, medical equipment and devices, and health and social care. Our unique perspective extends to healthcare IT which intersects all three areas, driving innovation and efficiency. With the freedom to challenge industry norms and deliver bold, insightful strategies, we provide deep expertise across pharma & life sciences, medical equipment & devices and health & social care.

Healthcare Trends & Considerations

M&A activity is rebounding as inflation and interest rates ease, lowering capital costs and boosting confidence. Healthcare remains strong, with a growing focus on prevention and outcomes. Expect more US-to-Europe M&A as American firms seek European expertise in wellness and IP. This shift signals rising interest in preventative care, natural products, and re-purposing existing therapies for new indications.

Expertise which leads the sector

Before we meet you, we identify buyers, investors, and industry dynamics, demonstrating deep expertise that builds trust. This knowledge-driven approach sets us apart, enabling us to deliver strategic, high-value outcomes for you that shape the sector.

We define sub-sectors, track market trends, and analyse key transactions to ensure we speak the same language as you.

Wellness, Vitamins, Minerals & Supplements: October 2025

Examine six fast-growing sectors; from vitamins and gut health to nootropics and matcha - highlighting major M&A trends, investor activity, and the expanding £8.2 trillion global wellness market.

Download report

Healthcare Report December 2025

Heligan’s November 2025 UK Healthcare M&A Update highlights a resilient deal market led by health and social care and medical devices, as buyers push for scale, specialisation and tech-enabled services despite ongoing cost pressures and macro uncertainty.

Download Report

Previous reports

Heligan Healthcare report Oct25
900979 Heligan Healthcarereport Sept25 Thumbnail
1000 700px Cover Thumb
Heligan Healthcarethumbnail
Heligan Healthcare Report April
900818 Heligan Healthcarereport March25 V3
900737 Heligan Healthcarereport February25 V3
Healthcare update January
Heligan Healthcare Reflecting report 2024

Contact our Healthcare sector experts

Complete the form to contact Heligan's specialist team to explore the report insights or discuss tailored solutions to your needs.

This firm is regulated by the Institute of Chartered Accountants in England and Wales for a range of investment business activities. This firm is not authorised under the Financial Services and Markets Act 2000 but we are able in certain circumstances to offer a limited range of investment services to clients because we are members of the Institute of Chartered Accountants in England and Wales. We can provide these investment services if they are an incidental part of the professional services we have been engaged to provide.

`
Investments
Strategic Insights
corporate finance
Wealth Management